226 related articles for article (PubMed ID: 26126434)
1. Is 5ยด-AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?
Kim WJ
Int Neurourol J; 2015 Jun; 19(2):55-66. PubMed ID: 26126434
[TBL] [Abstract][Full Text] [Related]
2. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.
Faubert B; Vincent EE; Poffenberger MC; Jones RG
Cancer Lett; 2015 Jan; 356(2 Pt A):165-70. PubMed ID: 24486219
[TBL] [Abstract][Full Text] [Related]
3. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.
Vazirian M; Nabavi SM; Jafari S; Manayi A
Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216
[TBL] [Abstract][Full Text] [Related]
4. The double-edged sword of AMPK signaling in cancer and its therapeutic implications.
Jeon SM; Hay N
Arch Pharm Res; 2015 Mar; 38(3):346-57. PubMed ID: 25575627
[TBL] [Abstract][Full Text] [Related]
5. The multifaceted activities of AMPK in tumor progression--why the "one size fits all" definition does not fit at all?
Bonini MG; Gantner BN
IUBMB Life; 2013 Nov; 65(11):889-96. PubMed ID: 24265196
[TBL] [Abstract][Full Text] [Related]
6. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells.
Wang Q; Luo C; Wu X; Du H; Song X; Fan Y
J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565
[TBL] [Abstract][Full Text] [Related]
7. Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
Kou B; Liu W; Xu X; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q
Oncol Rep; 2017 Nov; 38(5):3137-3143. PubMed ID: 29048631
[TBL] [Abstract][Full Text] [Related]
8. The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Vara-Ciruelos D; Russell FM; Hardie DG
Open Biol; 2019 Jul; 9(7):190099. PubMed ID: 31288625
[TBL] [Abstract][Full Text] [Related]
9. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
[TBL] [Abstract][Full Text] [Related]
10. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
[TBL] [Abstract][Full Text] [Related]
11. Indirect AMP-Activated Protein Kinase Activators Prevent Incision-Induced Hyperalgesia and Block Hyperalgesic Priming, Whereas Positive Allosteric Modulators Block Only Priming in Mice.
Inyang KE; Burton MD; Szabo-Pardi T; Wentworth E; McDougal TA; Ramirez ED; Pradhan G; Dussor G; Price TJ
J Pharmacol Exp Ther; 2019 Oct; 371(1):138-150. PubMed ID: 31324647
[TBL] [Abstract][Full Text] [Related]
12. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
Kang JI; Hong JY; Lee HJ; Bae SY; Jung C; Park HJ; Lee SK
PLoS One; 2015; 10(12):e0144368. PubMed ID: 26656173
[TBL] [Abstract][Full Text] [Related]
13. A novel dual AMPK activator/mTOR inhibitor inhibits thyroid cancer cell growth.
Plews RL; Mohd Yusof A; Wang C; Saji M; Zhang X; Chen CS; Ringel MD; Phay JE
J Clin Endocrinol Metab; 2015 May; 100(5):E748-56. PubMed ID: 25710562
[TBL] [Abstract][Full Text] [Related]
14. AMPK and autophagy in glucose/glycogen metabolism.
Ha J; Guan KL; Kim J
Mol Aspects Med; 2015 Dec; 46():46-62. PubMed ID: 26297963
[TBL] [Abstract][Full Text] [Related]
15. Role of AMP-activated protein kinase in cancer therapy.
Rehman G; Shehzad A; Khan AL; Hamayun M
Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
[TBL] [Abstract][Full Text] [Related]
16. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase.
Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH
Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587
[TBL] [Abstract][Full Text] [Related]
17. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
Costa C; Pereira S; Lima L; Peixoto A; Fernandes E; Neves D; Neves M; Gaiteiro C; Tavares A; Gil da Costa RM; Cruz R; Amaro T; Oliveira PA; Ferreira JA; Santos LL
PLoS One; 2015; 10(11):e0141253. PubMed ID: 26569621
[TBL] [Abstract][Full Text] [Related]
18. Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase.
Okubo K; Isono M; Asano T; Sato A
Transl Oncol; 2019 Apr; 12(4):669-682. PubMed ID: 30849634
[TBL] [Abstract][Full Text] [Related]
19. Targeting AMPK for cancer prevention and treatment.
Li W; Saud SM; Young MR; Chen G; Hua B
Oncotarget; 2015 Apr; 6(10):7365-78. PubMed ID: 25812084
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
